PHARMACODYNAMICS OF VENLAFAXINE EVALUATED BY EEG BRAIN MAPPING, PSYCHOMETRY AND PSYCHOPHYSIOLOGY.

1. In a double-blind, placebo-controlled study the effects of venlafaxine--a novel nontricyclic compound inhibiting neuronal uptake of serotonin, noradrenaline and to a lesser extent dopamine--were investigated utilizing EEG brain mapping, psychometric and psychophysiological measures. 2. Sixteen healthy volunteers (eight males, eight females) aged 21-36 years received randomized and at weekly intervals single oral doses of placebo, 12.5 mg, 25 mg and 50 mg venlafaxine. EEG recordings, psychometric and psychophysiological tests, and evaluation of pulse, blood pressure and side-effects were carried out at 0, 2, 4, 6, and 8 h. 3. EEG brain mapping demonstrated that venlafaxine exerted a significant action on human brain function as compared with placebo at all three doses, characterized mostly by attenuation of absolute power, increase of relative delta/theta and beta, and decrease of alpha power, as well as by an acceleration of the total centroid fronto-temporally and by its slowing centrally and parietally. These findings are similar to antidepressants such as imipramine. Topographically, drug-induced alterations were most pronounced over both fronto-temporal and the right temporal to temporo-occipital regions. 4. Psychometric and psychophysiological investigations demonstrated significant dose-dependent psychotropic properties of the drug. Multivariate statistics exhibited an improvement of both the noopsyche (e.g. attention, concentration, attention variability, memory, fine motor activity, reaction time performance) and thymopsyche (e.g. drive, wakefulness)) but also significant psychophysiological activation (e.g. in c.f.f., pupillary and skin conductance measures). 5. Time-efficiency calculations showed significant central effects from the 2nd hour onwards, with increasing differences between placebo and treatment up to the 8th hour. Nausea was the most frequent complaint and appeared dose dependent.

[1]  B Saletu,et al.  Topographic brain mapping of EEG in neuropsychopharmacology--Part I. Methodological aspects. , 1987, Methods and findings in experimental and clinical pharmacology.

[2]  J Grünberger,et al.  Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging). , 1987, Methods and findings in experimental and clinical pharmacology.

[3]  J. Haskins,et al.  Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. , 1986, Biochemical pharmacology.

[4]  Iain M McIntyre,et al.  Interpatient variations in antipsychotic therapy. , 1985, The Journal of clinical psychiatry.

[5]  B. Saletu,et al.  Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses. , 1985, The Journal of clinical psychiatry.

[6]  M. Matousek,et al.  Measurement of the Inter-Hemispheral Differences as a Diagnostic Tool in Psychiatry , 1981 .

[7]  F. Duffy,et al.  Significance probability mapping: an aid in the topographic analysis of brain electrical activity. , 1981, Electroencephalography and clinical neurophysiology.

[8]  M. Dubocovich,et al.  High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine. , 1980, Science.

[9]  R. Brumback,et al.  Neuropsychological Study of Children during and after Remission of Endogenous Depressive Episodes , 1980, Perceptual and motor skills.

[10]  M. Briley,et al.  Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding. , 1980, European journal of pharmacology.

[11]  J. Fleiss,et al.  Dichotic Perception: Evidence for Right Hemisphere Dysfunction in Affective Psychosis , 1979, British Journal of Psychiatry.

[12]  R. Waziri,et al.  Depression and Hemispheric Functions: Changes Associated with Unilateral ECT , 1978, British Journal of Psychiatry.

[13]  P. Flor-Henry.  LATERALIZED TEMPORAL‐LIMBIC DYSFUNCTION AND PSYCHOPATHOLOGY * , 1976 .

[14]  T. Itil.  Quantitative Pharmaco-Electroencephalography , 1974 .

[15]  P. Flor-Henry.  Psychosis, Neurosis and Epilepsy , 1974, British Journal of Psychiatry.

[16]  R. Davidson.  EEG measures of cerebral asymmetry: conceptual and methodological issues. , 1988, The International journal of neuroscience.

[17]  H. L. Goldberg,et al.  An open-label, variable-dose study of WY-45,030 (venlafexine) in depressed outpatients. , 1988, Psychopharmacology bulletin.

[18]  K. Rickels,et al.  An open-label, dose-finding study of WY-45,030, a novel bicyclic antidepressant. , 1988, Psychopharmacology bulletin.

[19]  L. Fabre,et al.  An ascending single-dose tolerance study of WY-45,030, a bicyclic antidepressant, in healthy men , 1987 .

[20]  P. Anderer,et al.  On the central effects of the GABA agonist fengabine: Psychometric and pharmaco‐EEG studies utilizing imaging methods , 1987 .

[21]  B. Saletu,et al.  Early clinical pharmacological studies with sercloremine—a novel antidepressant—utilizing pharmacokinetic, pharmaco‐EEG, and psychometric analyses , 1985 .

[22]  W. Herrmann.  Electroencephalography in drug research , 1982 .

[23]  T. Gasser,et al.  Transformations towards the normal distribution of broad band spectral parameters of the EEG. , 1982, Electroencephalography and clinical neurophysiology.

[24]  B. Saletu,et al.  The pharmacokinetics of nomifensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco-EEG. , 1982, International pharmacopsychiatry.

[25]  D. Tucker.  Asymmetrical Frontal Lobe Function during a Transient Depressive State , 1981 .

[26]  B. Saletu,et al.  Determination of pharmacodynamics of psychotropic drugs by psychometric analysis. , 1980, Progress in neuro-psychopharmacology.

[27]  P. Anderer,et al.  Classification and Assessment of Pharmacodynamics of SGD-SCHA1059 (Binodaline) by Quantitative EEG and Psychometric Analyses , 1980 .

[28]  L. von Knorring,et al.  Systemic structural analysis of the electroencephalogram of depressed patients. General principles and preliminary results of an international collaborative study. , 1978, Neuropsychobiology.

[29]  J. A. Subach,et al.  Significance Probability Mappings and Automated Interpretation of Complex Pictorial Scenes , 1976 .

[30]  M. Fink.  EEG and human psychopharmacology. , 1969, Annual review of pharmacology.